Evidence map›Paper›PMID 25521879›Full record

SynthesisAmerican journal of public health2015

Prescription drug insurance coverage and patient health outcomes: a systematic review.

Aaron S Kesselheim, Krista F Huybrechts, Niteesh K Choudhry, Lisa A Fulchino, Danielle L Isaman, Mary K Kowal, Troyen A Brennan

Abstract readSystematic Review
In one paragraph

Synthesis in American journal of public health, 2015. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 46 papers, 3 of them syntheses that pooled it.

0numbers the graph read from it
0cells of the map it votes in
46citing papers in PubMed, 3 pooled it
–field-weighted citation impact
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

46 citing papers in PubMed, 3 syntheses or guidelines pooled it.

  1. Pooled it
  2. Pooled it
  3. Guideline
  4. Trial
  5. Article
  6. Article
  7. Article
  8. Article
  9. Article
  10. Article
  11. Article
  12. Article
  13. Article
  14. Article
  15. Observational
  16. Determining the prevalence and risk factors for prescription drug unaffordability.Research in social & administrative pharmacy : RSAP · 2022
    Article
  17. Article
  18. CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2022
    Article
  19. Recommendations for equitable COVID-19 pandemic recovery in Canada.CMAJ : Canadian Medical Association journal = journal de l'Association medicale canadienne · 2021
    Article
  20. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors.

Aaron S KesselheimAaron S. Kesselheim, Krista F. Huybrechts, Niteesh K. Choudhry, Lisa A. Fulchino, Danielle L. Isaman, and Mary K. Kowal are with the Division of Pharmacoepidemiology and Pharmacoeconomics, Department of Medicine, Brigham and Women's Hospital and Harvard Medical School, Boston, MA. Troyen A. Brennan is with CVS Caremark, Woonsocket, RI.
Krista F Huybrechts
Niteesh K Choudhry
Lisa A Fulchino
Danielle L Isaman
Mary K Kowal
Troyen A Brennan

Funding

Improved methods to assess the comparative safety of new psychiatric medicationsK01MH099141 · NIMH · BRIGHAM AND WOMEN'S HOSPITAL · PI HUYBRECHTS, KRISTA F · 2013 to 2017
$882k
Off-label prescribing: Comparative evidence, regulation, and utilizationK08HS018465 · AHRQ · BRIGHAM AND WOMEN'S HOSPITAL · PI KESSELHEIM, AARON SETH · 2009 to 2013
$797k
AHRQ HHS K08 HS018465AHRQ HHS K08HS18465-01NIMH NIH HHS K01 MH099141
6 · The paper itself

Abstract

Previous reviews have shown that changes in prescription drug insurance benefits can affect medication use and adherence. We conducted a systematic review of the literature to identify studies addressing the association between prescription drug coverage and health outcomes. Studies were included if they collected empirical data on expansions or restrictions of prescription drug coverage and if they reported clinical outcomes. We found 23 studies demonstrating that broader prescription drug insurance reduces use of other health care services and has a positive impact on patient outcomes. Coverage gaps or caps on drug insurance generally led to worse outcomes. States should consider implementing the Affordable Care Act expansions in drug coverage to improve the health of low-income patients receiving state-based health insurance.

Indexed as

Insurance, Pharmaceutical ServicesHumansInsurance CoveragePatient Outcome AssessmentPatient Protection and Affordable Care ActPrescription DrugsUnited StatesPrescription Drugs

Identifiers

PMID25521879
PMCPMC4318289

What OpenQuestion holds

Textmetadata
LicenceTDM
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.